dr. terri febbraro on the inverse correlation between time on chemotherapy and os
Published 8 years ago • 568 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
51:15
controversy: do antioxidants help or hinder chemotherapy and radiation?
-
10:15
what tumors eat -- and how to poison them | dr. christal sohl | tedxtulsacc
-
0:36
discover the difference between adjuvant and neoadjuvant chemotherapy for breast cancer patients 🎗️🔬
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
2:11
dr. piccioni on tumor profiles of brain metastases
-
1:17
dr. choti on the benefits of neoadjuvant chemotherapy in pancreatic cancer
-
1:14
dr. cercek on chemotherapy resistance in dmmr rectal cancer
-
1:14
dr. minna on chemotherapy and radiation therapy for lung cancer
-
1:16
dr. terry mamounas on the results from nsabp b-28 study and oncotype dx - 2012 sabcs
-
0:43
understanding the benefits and risks of chemotherapy for breast cancer patients 🎗️💊
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer
-
34:39
bladder cancer and immunotherapy with dr. arjun balar
-
52:39
chemotherapy for brain and spine tumors: why do we use it and what to expect
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:35
dr. pat whitworth discusses treating breast cancer with chemotherapy
-
1:58
dr. patel on combination chemotherapy and immunotherapy in lung cancer
-
0:50
bacteria can chew up all the chemotherapy